Molecular Partners Ag (MOLN) Accumulated Expenses (2020 - 2025)

Molecular Partners Ag (MOLN) has disclosed Accumulated Expenses for 6 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 14.52% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Dec 2025, up 14.52% year-over-year, with the annual reading at $9.7 million for FY2025, 10.87% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $10.1 million at Molecular Partners Ag, up from $8.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $10.8 million in Q4 2021, with the low at $7.8 million in Q4 2022.
  • Average Accumulated Expenses over 5 years is $9.2 million, with a median of $8.8 million recorded in 2024.
  • The sharpest move saw Accumulated Expenses rose 26.71% in 2021, then fell 28.02% in 2022.
  • Over 5 years, Accumulated Expenses stood at $10.8 million in 2021, then dropped by 28.02% to $7.8 million in 2022, then increased by 9.27% to $8.5 million in 2023, then increased by 3.43% to $8.8 million in 2024, then rose by 14.52% to $10.1 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $10.1 million, $8.8 million, and $8.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.